Advocacy intelligence hub — real-time data for patient organizations
University of Pennsylvania — PHASE2
National Cancer Institute (NCI) — PHASE2
Assistance Publique - Hôpitaux de Paris — PHASE2
National Cancer Institute (NCI) — PHASE2
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Beijing VDJBio Co., LTD. — PHASE2
National Cancer Institute (NCI)
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
University of Pennsylvania — PHASE2
National Cancer Institute (NCI)
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Robert Yarchoan, M.D.
National Cancer Institute (NCI)
📍 Bethesda, Maryland
Ramya M Ramaswami, M.D.
National Cancer Institute (NCI)
📍 Bethesda, Maryland
Joshua Brandstadter, MD, PhD, MSc, M.D., PhD
University of Pennsylvania
📍 PHILADELPHIA, PA
Pier Luigi Zinzani, MD
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Jian li, M.D.
Peking Union Medical College Hospital
Matthew Painschab, MD, MD
University of North Carolina
📍 INDIANAPOLIS, IN